Preface |
|
xx | |
List of Contributors |
|
xxi | |
About the Companion Website |
|
xxiii | |
1 Cardiovascular Disease |
|
1 | (85) |
|
|
|
1 | (1) |
|
Cardiovascular Physiology |
|
|
2 | (4) |
|
Tissue Perfusion and Oxygen Delivery |
|
|
2 | (1) |
|
Blood Pressure and Cardiac Output |
|
|
2 | (1) |
|
Mean Arterial Pressure and Autoregulation |
|
|
2 | (1) |
|
|
2 | (2) |
|
Relationship Between Mean Arterial Pressure and Cardiac Output |
|
|
4 | (2) |
|
Preanesthetic Patient Assessment |
|
|
6 | (1) |
|
Functional Classification of Cardiac Disease |
|
|
7 | (1) |
|
Sedation Versus General Anesthesia |
|
|
7 | (1) |
|
Anesthetic and Analgesic Agents |
|
|
8 | (9) |
|
|
8 | (4) |
|
|
12 | (1) |
|
|
13 | (4) |
|
|
17 | (1) |
|
Local and Regional Anesthesia and Analgesia |
|
|
17 | (1) |
|
Systemic Analgesic Infusions |
|
|
18 | (1) |
|
Nonsteroidal Anti-Inflammatory Drugs |
|
|
18 | (1) |
|
Sympathomimetic Drugs: Inotropes and Vasopressors |
|
|
18 | (4) |
|
|
19 | (1) |
|
|
19 | (2) |
|
|
21 | (1) |
|
|
21 | (1) |
|
|
21 | (1) |
|
|
21 | (1) |
|
|
22 | (1) |
|
Patient Monitoring and Support |
|
|
22 | (6) |
|
|
22 | (1) |
|
|
22 | (1) |
|
|
23 | (2) |
|
|
25 | (1) |
|
|
25 | (1) |
|
|
25 | (1) |
|
Capnometry and Ventilation |
|
|
26 | (1) |
|
|
27 | (1) |
|
Central Venous Pressure (CVP) |
|
|
27 | (1) |
|
Arterial Pulse Pressure Variation (PPV) |
|
|
27 | (1) |
|
Anesthetic and Pharmacologic Recommendations for Specific Cardiac Diseases |
|
|
28 | (21) |
|
General Preanesthetic Evaluation |
|
|
28 | (1) |
|
|
28 | (6) |
|
Congenital Cardiac Disease |
|
|
34 | (3) |
|
Abnormalities of Cardiac Conduction and Cardiac Rhythm |
|
|
37 | (12) |
|
Cardiac Pacemakers and Pacing |
|
|
49 | (3) |
|
|
49 | (3) |
|
Systemic and Pulmonary Arterial Hypertension |
|
|
52 | (4) |
|
|
52 | (2) |
|
Pulmonary Arterial Hypertension (PAH) |
|
|
54 | (2) |
|
|
56 | (4) |
|
|
56 | (1) |
|
|
56 | (2) |
|
|
58 | (2) |
|
Canine and Feline Cardiomyopathies |
|
|
60 | (6) |
|
Hypertrophic Cardiomyopathy |
|
|
61 | (2) |
|
|
63 | (2) |
|
Arrhythmogenic Cardiomyopathy |
|
|
65 | (1) |
|
|
66 | (2) |
|
Incidence and Pathophysiology |
|
|
66 | (1) |
|
|
66 | (1) |
|
|
67 | (1) |
|
|
67 | (1) |
|
|
68 | (1) |
|
|
68 | (18) |
2 Respiratory Disease |
|
86 | (24) |
|
|
|
|
86 | (1) |
|
|
86 | (1) |
|
Respiratory Volumes and Ventilation |
|
|
87 | (2) |
|
|
89 | (4) |
|
|
89 | (2) |
|
|
91 | (2) |
|
Interactions Between CO2 and O2 Transport |
|
|
93 | (1) |
|
Ventilatory Cycle Phases and Ventilatory Support |
|
|
93 | (2) |
|
|
93 | (1) |
|
Ventilatory Support with Intermittent Positive Pressure Ventilation (IPPV) |
|
|
93 | (2) |
|
|
95 | (1) |
|
Ventilation in Conscious Patients |
|
|
96 | (1) |
|
Pharmacologic Effects on Ventilation |
|
|
96 | (2) |
|
|
96 | (1) |
|
Other Sedatives and Tranquilizers |
|
|
96 | (1) |
|
Injectable and Inhalant Anesthetics |
|
|
97 | (1) |
|
Anesthetic Management of Specific Disorders |
|
|
98 | (6) |
|
Upper Airway Disorders or Dysfunction |
|
|
98 | (4) |
|
Lower Airway and Parenchymal Diseases |
|
|
102 | (2) |
|
Extrapulmonary or Thoracic Wall Disease |
|
|
104 | (1) |
|
|
104 | (1) |
|
|
105 | (5) |
3 Neurologic Disease |
|
110 | (24) |
|
|
|
|
110 | (1) |
|
Nervous System Physiology |
|
|
110 | (3) |
|
|
110 | (1) |
|
|
111 | (1) |
|
Cerebral Perfusion Pressure and Mean Arterial Pressure |
|
|
112 | (1) |
|
|
112 | (1) |
|
Arterial Partial Pressure of Carbon Dioxide and Oxygen |
|
|
112 | (1) |
|
|
113 | (1) |
|
|
113 | (1) |
|
Anesthesia of Patients with Neurologic Conditions |
|
|
113 | (2) |
|
Preanesthetic Considerations |
|
|
113 | (1) |
|
|
113 | (1) |
|
|
114 | (1) |
|
Methods to Manage Increased Intracranial Pressure |
|
|
114 | (1) |
|
|
115 | (3) |
|
|
115 | (1) |
|
|
116 | (1) |
|
|
117 | (1) |
|
|
118 | (1) |
|
Anesthetic Management of Specific Disease Processes |
|
|
118 | (7) |
|
|
118 | (1) |
|
|
119 | (1) |
|
|
120 | (1) |
|
|
121 | (1) |
|
Chiari-Like Malformation and Syringomyelia |
|
|
122 | (1) |
|
Intervertebral Disc Disease and Other Spinal Injuries |
|
|
122 | (1) |
|
|
123 | (1) |
|
Other Nervous System Disorders |
|
|
123 | (1) |
|
Postoperative Cognitive Dysfunction |
|
|
124 | (1) |
|
|
125 | (9) |
4 Hepatobiliary Disease |
|
134 | (21) |
|
|
|
134 | (1) |
|
|
134 | (2) |
|
Markers of Hepatic Dysfunction |
|
|
136 | (1) |
|
Perioperative Effects on Hepatic Function |
|
|
137 | (1) |
|
General Anesthetic Effects |
|
|
137 | (1) |
|
|
138 | (1) |
|
Hepatic Dysfunction and Pharmacological Agents |
|
|
138 | (4) |
|
|
138 | (2) |
|
|
140 | (1) |
|
Nonsteroidal Anti-Inflammatory Agents |
|
|
140 | (1) |
|
|
141 | (1) |
|
|
142 | (1) |
|
Anesthetic Management of Patients with Hepatic Dysfunction |
|
|
142 | (6) |
|
|
143 | (1) |
|
|
144 | (1) |
|
|
144 | (2) |
|
Hepatic Neoplasia Resection |
|
|
146 | (1) |
|
|
147 | (1) |
|
|
148 | (1) |
|
|
148 | (7) |
5 Gastrointestinal Disease |
|
155 | (47) |
|
Juliana Peboni Figueiredo |
|
|
Gastrointestinal (GI) Tract Function |
|
|
155 | (1) |
|
|
155 | (9) |
|
|
155 | (2) |
|
|
157 | (1) |
|
|
157 | (7) |
|
|
164 | (10) |
|
|
164 | (1) |
|
|
165 | (1) |
|
|
166 | (1) |
|
|
166 | (1) |
|
|
167 | (1) |
|
|
167 | (7) |
|
Gastric and Small Intestinal Disease |
|
|
174 | (13) |
|
|
175 | (1) |
|
|
176 | (1) |
|
|
176 | (4) |
|
Gastric Dilatation-Volvulus |
|
|
180 | (7) |
|
Colonic, Rectal, Anal, and Perineal Surgery |
|
|
187 | (5) |
|
|
188 | (2) |
|
|
190 | (1) |
|
Anesthetic Considerations |
|
|
190 | (1) |
|
Secondary Septic Peritonitis |
|
|
191 | (1) |
|
Anesthetic Considerations |
|
|
191 | (1) |
|
|
192 | (1) |
|
|
192 | (10) |
6 Renal Disease |
|
202 | (23) |
|
|
|
202 | (1) |
|
|
202 | (5) |
|
|
203 | (3) |
|
Renal Disease and Surgery |
|
|
206 | (1) |
|
Renal Disease and Pharmacologic Agents |
|
|
207 | (6) |
|
|
207 | (3) |
|
|
210 | (1) |
|
|
211 | (1) |
|
|
212 | (1) |
|
Anesthetic Management of Patients with Renal Disease |
|
|
213 | (4) |
|
Pre-anesthetic Stabilization |
|
|
213 | (3) |
|
Intraoperative Management |
|
|
216 | (1) |
|
|
217 | (1) |
|
|
217 | (8) |
7 Urogenital Concerns |
|
225 | (37) |
|
|
|
225 | (1) |
|
|
225 | (1) |
|
|
225 | (15) |
|
Clinical Signs and Physical Examination |
|
|
226 | (1) |
|
Initial Database and Clinicopathology |
|
|
226 | (2) |
|
Preanesthetic Management and Initial Stabilization |
|
|
228 | (7) |
|
|
235 | (3) |
|
Adjunctive Anesthetic Techniques |
|
|
238 | (1) |
|
|
239 | (1) |
|
Recovery and Postoperative Care |
|
|
240 | (1) |
|
Upper Urinary Tract Obstruction |
|
|
240 | (4) |
|
Clinical Signs and Physical Exam |
|
|
240 | (1) |
|
Initial Database and Stabilization |
|
|
240 | (2) |
|
|
242 | (1) |
|
Recovery and Postoperative Care |
|
|
243 | (1) |
|
|
244 | (6) |
|
Clinical Signs and Physical Exam |
|
|
244 | (1) |
|
Initial Database and Clinicopathology |
|
|
245 | (1) |
|
Preanesthetic Management and Initial Stabilization |
|
|
246 | (1) |
|
|
247 | (1) |
|
|
248 | (1) |
|
Recovery and Postoperative Care |
|
|
249 | (1) |
|
|
250 | (4) |
|
Clinical Signs and Physical Exam |
|
|
250 | (1) |
|
Initial Database and Clinicopathology |
|
|
250 | (1) |
|
Preanesthetic Management and Initial Stabilization |
|
|
251 | (1) |
|
Anesthesia and Monitoring |
|
|
252 | (2) |
|
Recovery and Postoperative Care |
|
|
254 | (1) |
|
Nonurgent Urogenital Procedures |
|
|
254 | (1) |
|
Laparoscopic Urogenital Procedures |
|
|
254 | (1) |
|
|
254 | (1) |
|
|
255 | (1) |
|
Urinary Tract Diagnostic Imaging |
|
|
255 | (2) |
|
|
256 | (1) |
|
Cystography/Urethrography |
|
|
256 | (1) |
|
|
257 | (5) |
8 Perioperative Fluid, Electrolyte, and Acid-Base Disturbances |
|
262 | (37) |
|
|
|
262 | (1) |
|
|
263 | (7) |
|
Dehydration and Intravascular Volume Deficits |
|
|
265 | (5) |
|
|
270 | (16) |
|
|
270 | (5) |
|
|
275 | (2) |
|
|
277 | (5) |
|
|
282 | (4) |
|
Acid-Base Homeostasis and Disturbances |
|
|
286 | (7) |
|
|
286 | (3) |
|
|
289 | (1) |
|
|
290 | (1) |
|
|
291 | (1) |
|
Stepwise Approach to Acid-Base Status Assessment |
|
|
292 | (1) |
|
Stepwise Approach to the Anesthetic Management of the Patient with an Acid-Base Disorder |
|
|
292 | (1) |
|
|
293 | (6) |
9 Endocrine Disease |
|
299 | (37) |
|
|
|
299 | (1) |
|
|
299 | (10) |
|
Thyroid Gland Anatomy and Physiology |
|
|
299 | (1) |
|
|
299 | (1) |
|
|
299 | (5) |
|
|
304 | (5) |
|
|
309 | (8) |
|
Adrenal Gland Anatomy and Physiology |
|
|
309 | (1) |
|
Hyperadrenocorticism (HAC; Cushing's Disease) |
|
|
309 | (5) |
|
Hypoadrenocorticism (Addison's Disease) |
|
|
314 | (3) |
|
|
317 | (7) |
|
|
317 | (7) |
|
|
324 | (5) |
|
|
324 | (1) |
|
|
324 | (1) |
|
Clinical Signs and Symptoms |
|
|
324 | (1) |
|
Clinicopathologic Changes |
|
|
324 | (1) |
|
|
325 | (1) |
|
|
325 | (1) |
|
|
325 | (1) |
|
Diabetic Ketoacidosis (DKA) |
|
|
326 | (3) |
|
|
329 | (1) |
|
|
329 | (7) |
10 Nutritional Disease |
|
336 | (9) |
|
|
|
336 | (1) |
|
|
336 | (2) |
|
Anesthetic Management of the Obese Patient |
|
|
338 | (3) |
|
|
338 | (1) |
|
|
339 | (2) |
|
|
341 | (1) |
|
|
341 | (1) |
|
Additional Nutritional Concerns |
|
|
341 | (2) |
|
Boutique Diets (Grain-Free Diets, Novel Protein Diets, All-Meat Diet) |
|
|
341 | (1) |
|
|
342 | (1) |
|
|
343 | (1) |
|
|
343 | (2) |
11 Genetic Disease |
|
345 | (14) |
|
|
|
345 | (1) |
|
|
345 | (1) |
|
Genetically Related Diseases |
|
|
346 | (9) |
|
Breed-Related Differences |
|
|
346 | (1) |
|
Drug Metabolism and Disposition |
|
|
346 | (1) |
|
|
347 | (1) |
|
|
348 | (3) |
|
|
351 | (1) |
|
|
351 | (1) |
|
Brachycephalic Airway Obstruction Syndrome (BAOS) |
|
|
351 | (2) |
|
von Willebrand Disease (VWD) |
|
|
353 | (2) |
|
|
355 | (1) |
|
|
355 | (4) |
12 Anesthesia for Ophthalmic Patients |
|
359 | (14) |
|
|
|
359 | (1) |
|
|
359 | (1) |
|
|
360 | (1) |
|
|
361 | (1) |
|
Oculocardiac Reflex (Aschner Reflex) |
|
|
361 | (1) |
|
|
362 | (4) |
|
Drugs Used to Treat Glaucoma |
|
|
362 | (1) |
|
|
363 | (1) |
|
Drugs Used to Dilate the Pupil |
|
|
363 | (1) |
|
The Presence of Coexisting Disease |
|
|
363 | (1) |
|
Neuromuscular Blockade and Ventilation |
|
|
363 | (3) |
|
|
366 | (4) |
|
|
366 | (1) |
|
|
367 | (1) |
|
Nonsteroidal Anti-Inflammatory Drugs |
|
|
368 | (1) |
|
|
368 | (1) |
|
|
369 | (1) |
|
|
370 | (1) |
|
|
370 | (3) |
13 Oral and Maxillofacial Disorders |
|
373 | (22) |
|
|
|
|
373 | (1) |
|
Locoregional Anesthetic/Analgesic Agents |
|
|
374 | (1) |
|
Locoregional Agent Administration |
|
|
375 | (1) |
|
Maxillofacial Locoregional Techniques |
|
|
376 | (10) |
|
Specific Regional and Local Blocks |
|
|
377 | (8) |
|
Complications and Contraindications |
|
|
385 | (1) |
|
Inflammation and Local Anesthetic Efficacy |
|
|
386 | (1) |
|
Pathology Chronicity and Analgesic Needs |
|
|
387 | (1) |
|
Anesthetic Management of Other Oral and Maxillofacial Conditions |
|
|
387 | (1) |
|
Oral and Maxillofacial Trauma |
|
|
387 | (1) |
|
Oral and Maxillofacial Surgery |
|
|
387 | (1) |
|
Long-Acting Local Anesthetics-Bupivacaine |
|
|
388 | (1) |
|
Buprenorphine Combined with Local Anesthetics |
|
|
388 | (1) |
|
Local Anesthetic Redosing |
|
|
388 | (1) |
|
Intraoperative and Postoperative Continuous Rate Infusions |
|
|
388 | (1) |
|
Circumstances Requiring Unique Anesthetic Management Approaches |
|
|
388 | (4) |
|
|
388 | (1) |
|
|
389 | (2) |
|
Maxillomandibular Fixation |
|
|
391 | (1) |
|
Other Oral and Maxillofacial Surgery Techniques |
|
|
391 | (1) |
|
|
391 | (1) |
|
|
392 | (3) |
14 Hematologic Disorders |
|
395 | (31) |
|
|
|
|
395 | (1) |
|
Oxygen Content Monitoring in the Anesthetized Patient |
|
|
396 | (5) |
|
Red Blood Cell Transfusions |
|
|
401 | (2) |
|
Anesthetic Considerations for Patients with Anemia |
|
|
403 | (2) |
|
Red Blood Cell Disorders and Blood Viscosity |
|
|
405 | (1) |
|
|
406 | (1) |
|
|
406 | (6) |
|
|
406 | (1) |
|
Evaluation of Primary Hemostasis |
|
|
406 | (1) |
|
Disorders of Primary Hemostasis |
|
|
407 | (1) |
|
Treatments in Preparation for Anesthesia |
|
|
408 | (1) |
|
|
409 | (3) |
|
|
412 | (3) |
|
Evaluation of Secondary Hemostasis |
|
|
412 | (1) |
|
Disorders of Secondary Hemostasis |
|
|
412 | (3) |
|
Viscoelastic Coagulation Monitoring |
|
|
415 | (1) |
|
Disseminated Intravascular Coagulopathy |
|
|
416 | (2) |
|
|
418 | (1) |
|
Disorders of Fibrinolysis |
|
|
419 | (1) |
|
|
419 | (7) |
15 Skin and Musculoskeletal. Diseases |
|
426 | (37) |
|
|
|
426 | (1) |
|
|
426 | (5) |
|
Metabolic Derangements and Systemic Effects |
|
|
427 | (1) |
|
Treatment and Anesthetic Management |
|
|
428 | (3) |
|
Chronic Pain Syndrome after Feline Onychectomy |
|
|
431 | (4) |
|
Anesthesia and Perioperative Analgesia |
|
|
432 | (2) |
|
Chronic Pain Syndrome Treatment |
|
|
434 | (1) |
|
|
435 | (3) |
|
|
435 | (1) |
|
|
436 | (1) |
|
|
436 | (2) |
|
|
438 | (4) |
|
|
438 | (1) |
|
|
438 | (1) |
|
|
439 | (1) |
|
|
439 | (3) |
|
|
442 | (4) |
|
|
443 | (1) |
|
|
443 | (1) |
|
Treatment and Anesthetic Management |
|
|
443 | (3) |
|
|
446 | (4) |
|
|
446 | (2) |
|
|
448 | (1) |
|
|
448 | (1) |
|
Anesthetic and Analgesic Management |
|
|
448 | (2) |
|
|
450 | (1) |
|
Noninfectious Inflammatory Joint Diseases |
|
|
450 | (4) |
|
|
451 | (1) |
|
Systemic Lupus Erythematosus |
|
|
452 | (1) |
|
|
453 | (1) |
|
|
454 | (1) |
|
Skin (Intradermal) Testing |
|
|
454 | (1) |
|
|
455 | (1) |
|
|
456 | (7) |
16 Infectious Disease |
|
463 | (39) |
|
|
|
|
463 | (1) |
|
Contamination and Cleaning of Anesthetic Equipment |
|
|
463 | (1) |
|
|
463 | (1) |
|
|
464 | (1) |
|
Anesthetic Equipment and Monitors |
|
|
464 | (1) |
|
Multidrug-Resistant Organisms and Surgical Site Infection |
|
|
464 | (4) |
|
Multidrug-Resistant Organisms |
|
|
464 | (2) |
|
|
466 | (2) |
|
|
468 | (7) |
|
Aspiration, Bacterial, and Viral Pneumonia |
|
|
468 | (3) |
|
|
471 | (3) |
|
Feline Respiratory Disease Complex |
|
|
474 | (1) |
|
Gastrointestinal Infections |
|
|
475 | (2) |
|
Infectious Gastroenteritis |
|
|
475 | (2) |
|
|
477 | (4) |
|
Catheter- and Drug-Related Infections |
|
|
477 | (1) |
|
|
478 | (1) |
|
|
479 | (1) |
|
|
480 | (1) |
|
|
481 | (4) |
|
|
482 | (1) |
|
|
482 | (1) |
|
|
482 | (3) |
|
|
485 | (2) |
|
|
485 | (2) |
|
Additional Common Infectious Diseases |
|
|
487 | (6) |
|
|
487 | (1) |
|
|
488 | (2) |
|
|
490 | (2) |
|
Feline Immunodeficiency Virus and Feline Leukemia Virus |
|
|
492 | (1) |
|
|
493 | (9) |
17 Neoptastic Disease |
|
502 | (64) |
|
|
|
502 | (1) |
|
Pathophysiologic Considerations |
|
|
502 | (12) |
|
|
503 | (8) |
|
|
511 | (3) |
|
|
514 | (16) |
|
|
514 | (1) |
|
|
514 | (1) |
|
Specific Pain Characteristics |
|
|
515 | (6) |
|
|
521 | (9) |
|
Nursing Care of Hospitalized Patients |
|
|
530 | (1) |
|
Considerations for General Anesthesia |
|
|
530 | (2) |
|
Effects of Perioperative Management on Postoperative Oncologic Outcomes |
|
|
532 | (7) |
|
|
532 | (1) |
|
|
533 | (1) |
|
Analgesic Agents and Analgesic Techniques |
|
|
534 | (5) |
|
|
539 | (2) |
|
|
539 | (2) |
|
Acupuncture for the Oncologic Patient |
|
|
541 | (1) |
|
Alternative Analgesic Options in Palliative Care |
|
|
541 | (2) |
|
|
541 | (1) |
|
|
541 | (1) |
|
Subcutaneous Opioid Infusion and Other Opioid Delivery Routes |
|
|
542 | (1) |
|
Joint Injections for Osteoarthritis |
|
|
542 | (1) |
|
|
542 | (1) |
|
|
542 | (1) |
|
|
543 | (1) |
|
|
543 | (1) |
|
|
543 | (23) |
18 Cesarean Section and Pregnancy |
|
566 | (19) |
|
|
|
|
566 | (1) |
|
|
566 | (2) |
|
|
566 | (2) |
|
|
568 | (1) |
|
Central Nervous System (CNS) |
|
|
568 | (1) |
|
|
568 | (2) |
|
Opioid and Nonsteroidal Anti-Inflammatory Drug Effects on Maternal and Fetal Physiology |
|
|
570 | (1) |
|
|
570 | (1) |
|
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) |
|
|
571 | (1) |
|
Patient Management for Cesarean Section |
|
|
571 | (6) |
|
Preoperative Considerations |
|
|
571 | (2) |
|
Anesthetic Induction and Intraoperative Management |
|
|
573 | (3) |
|
Postoperative Pain Management |
|
|
576 | (1) |
|
|
577 | (2) |
|
|
579 | (1) |
|
Pregnant Patient Management for Noncesarean-Section Surgery |
|
|
580 | (1) |
|
|
581 | (4) |
19 Neonatal and Pediatric Concerns |
|
585 | (10) |
|
|
|
585 | (1) |
|
Physiological Alterations |
|
|
585 | (3) |
|
|
585 | (1) |
|
|
586 | (1) |
|
|
587 | (1) |
|
|
588 | (1) |
|
|
588 | (1) |
|
Pharmacokinetic and Pharmacodynamic Considerations |
|
|
588 | (1) |
|
Anesthetic Management of Neonatal and Pediatric Patients |
|
|
589 | (3) |
|
|
589 | (1) |
|
|
589 | (1) |
|
Anesthetic Induction and Maintenance |
|
|
590 | (1) |
|
|
591 | (1) |
|
|
592 | (1) |
|
|
592 | (1) |
|
|
592 | (3) |
20 Senior and Geriatric Concerns |
|
595 | (11) |
|
|
|
595 | (1) |
|
Physiological Alterations |
|
|
595 | (4) |
|
|
595 | (1) |
|
|
596 | (1) |
|
|
597 | (1) |
|
Central Nervous System (CNS) |
|
|
597 | (1) |
|
|
598 | (1) |
|
Gastrointestinal (GI) System |
|
|
598 | (1) |
|
|
599 | (1) |
|
Pharmacokinetic and Pharmacodynamic Considerations |
|
|
599 | (1) |
|
Anesthetic Management of Senior and Geriatric Patients |
|
|
599 | (4) |
|
|
600 | (1) |
|
|
600 | (1) |
|
Anesthetic Induction and Maintenance |
|
|
601 | (1) |
|
|
601 | (2) |
|
|
603 | (1) |
|
|
603 | (1) |
|
|
603 | (3) |
21 Disorders Related to Trauma |
|
606 | (18) |
|
|
|
606 | (1) |
|
Initial Patient Evaluation |
|
|
607 | (1) |
|
Anesthesia in Severe Trauma Patients |
|
|
608 | (7) |
|
|
610 | (3) |
|
Thoracic and Abdominal Trauma |
|
|
613 | (1) |
|
|
614 | (1) |
|
Analgesia in Severe Trauma Patients |
|
|
615 | (4) |
|
Pain Effects in Polytrauma Patients |
|
|
616 | (3) |
|
|
619 | (1) |
|
|
619 | (5) |
22 Nociceptive Disorders |
|
624 | (17) |
|
|
|
624 | (1) |
|
|
624 | (1) |
|
|
625 | (2) |
|
|
625 | (1) |
|
|
626 | (1) |
|
|
626 | (1) |
|
|
627 | (1) |
|
Supraspinal Modulation (Perception) |
|
|
627 | (1) |
|
Nociception and Pain Disorders |
|
|
627 | (3) |
|
Peripheral Sensitization (Wind-Up) |
|
|
627 | (1) |
|
Central Sensitization (Wind-Up) |
|
|
627 | (1) |
|
Chronic or Maladaptive Pain |
|
|
628 | (1) |
|
|
629 | (1) |
|
Preventive and Multimodal Analgesia |
|
|
629 | (1) |
|
Practical Anesthetic and Analgesic Considerations |
|
|
630 | (5) |
|
Common Analgesic Categories Used in Small-Animal Veterinary Medicine |
|
|
630 | (3) |
|
|
633 | (2) |
|
|
635 | (1) |
|
|
635 | (2) |
|
Immediate Postoperative Care |
|
|
635 | (2) |
|
Long-Term Postoperative Care |
|
|
637 | (1) |
|
|
637 | (4) |
23 Cardiopulmonary Resuscitation and Postcardiac Arrest Care |
|
641 | (21) |
|
|
|
641 | (1) |
|
CPR Preparedness and Prevention |
|
|
641 | (4) |
|
|
645 | (2) |
|
|
647 | (2) |
|
|
649 | (1) |
|
|
650 | (2) |
|
Clinical Application of the RECOVER Guidelines for Veterinary CPR |
|
|
652 | (5) |
|
|
657 | (1) |
|
|
657 | (2) |
|
CPR Recommendations in a Cat Sedated with Preanesthetic Medication Before an Elective Laceration Repair |
|
|
659 | (1) |
|
|
659 | (1) |
|
|
660 | (1) |
|
CPR Recommendations for a Dog During Anesthesia for an Elective Ovariohysterectomy |
|
|
660 | (1) |
|
|
660 | (1) |
|
|
660 | (1) |
|
CPR Recommendations During an Abdominal Exploratory of a Dog with a Hemoperitoneum Secondary to a Ruptured Splenic Mass |
|
|
661 | (1) |
|
|
661 | (1) |
|
|
661 | (1) |
Index |
|
662 | |